CS236663B2 - Manufacturing process of macro antibiotics 2%-dihydro-2%-deoxy-5-%-mycaminosyltylonolide - Google Patents

Manufacturing process of macro antibiotics 2%-dihydro-2%-deoxy-5-%-mycaminosyltylonolide Download PDF

Info

Publication number
CS236663B2
CS236663B2 CS818255A CS825581A CS236663B2 CS 236663 B2 CS236663 B2 CS 236663B2 CS 818255 A CS818255 A CS 818255A CS 825581 A CS825581 A CS 825581A CS 236663 B2 CS236663 B2 CS 236663B2
Authority
CS
Czechoslovakia
Prior art keywords
omt
dmt
formula
medium
antibiotic
Prior art date
Application number
CS818255A
Other languages
Czech (cs)
English (en)
Inventor
Richard H Baltz
Herbert A Kirst
Gene M Wild
Eugene T Seno
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CS236663B2 publication Critical patent/CS236663B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • C12R2001/54—Streptomyces fradiae
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y10S435/896—Streptomyces fradiae

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
CS818255A 1980-11-10 1981-11-10 Manufacturing process of macro antibiotics 2%-dihydro-2%-deoxy-5-%-mycaminosyltylonolide CS236663B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/205,539 US4304856A (en) 1980-11-10 1980-11-10 Process for producing 20-dihydro-20-deoxy-23-demycinosyltylosin

Publications (1)

Publication Number Publication Date
CS236663B2 true CS236663B2 (en) 1985-05-15

Family

ID=22762621

Family Applications (1)

Application Number Title Priority Date Filing Date
CS818255A CS236663B2 (en) 1980-11-10 1981-11-10 Manufacturing process of macro antibiotics 2%-dihydro-2%-deoxy-5-%-mycaminosyltylonolide

Country Status (22)

Country Link
US (1) US4304856A (el)
EP (1) EP0052005B1 (el)
JP (1) JPS57108097A (el)
KR (1) KR850001666B1 (el)
AR (1) AR227563A1 (el)
AU (1) AU7731381A (el)
BG (1) BG36939A3 (el)
CA (1) CA1169374A (el)
CS (1) CS236663B2 (el)
DD (1) DD202032A5 (el)
DE (1) DE3168693D1 (el)
DK (1) DK494381A (el)
FI (1) FI813527L (el)
GB (1) GB2086902B (el)
GR (1) GR75386B (el)
HU (1) HU190360B (el)
IE (1) IE51826B1 (el)
IL (1) IL64240A (el)
PH (1) PH17375A (el)
PL (1) PL233747A1 (el)
PT (1) PT73947B (el)
ZA (1) ZA817718B (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419508A (en) * 1980-11-10 1983-12-06 Eli Lilly And Company 20-Dihydro-20-deoxy-23-demycinosyltylosin and process for its production
AU551142B2 (en) * 1981-07-09 1986-04-17 Zaidan Hojin Biseibutsu Kagaku Kenkyukai Tylosin derivatives
US4423148A (en) * 1982-07-02 1983-12-27 Eli Lilly And Company Process for producing 20-dihydro-20-deoxy-23-de(mycinosyloxy)tylosin
US4528369A (en) * 1982-07-02 1985-07-09 Eli Lilly And Company 20-Dihydro-20-deoxy-23-de(mycinosyloxy)tylosin
US4452784A (en) * 1982-07-19 1984-06-05 Eli Lilly And Company C-23-Modified derivatives of DMT
US4443436A (en) * 1982-09-13 1984-04-17 Eli Lilly And Company C-20-Modified macrolide derivatives of the macrolide antibiotics tylosin, desmycosin, macrocin, and lactenocin
US4629786A (en) * 1983-02-28 1986-12-16 Eli Lilly And Company C-20- and C-23 modified macrolide derivatives
US4468511A (en) * 1983-02-28 1984-08-28 Eli Lilly And Company C-20- And C-23-Modified macrolide derivatives
IL71032A0 (en) * 1983-02-28 1984-05-31 Lilly Co Eli C-20 and c-23-modified macrolide derivatives
ATE151767T1 (de) * 1993-07-15 1997-05-15 Pfizer Amid-derivate von 16-gliedrige heterocyclen als antibiotische macrolide
US6362009B1 (en) 1997-11-21 2002-03-26 Merck & Co., Inc. Solid phase synthesis of heterocycles

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3178341A (en) * 1960-06-27 1965-04-13 Lilly Co Eli Antibiotics tylosin and desmycosin and derivatives thereof
US3326759A (en) * 1962-07-19 1967-06-20 Lilly Co Eli Antibiotics macrocin and lactenocin
US3344024A (en) * 1963-04-17 1967-09-26 American Cyanamid Co Antibiotic am-684 and method of production
BE667952A (el) * 1964-08-05
US4161523A (en) * 1972-11-15 1979-07-17 Schering Corporation Rosamicin esters, acid addition salts and methods for production thereof
US4056616A (en) * 1976-03-05 1977-11-01 Schering Corporation Rosamicin derivatives and method of using same
GB1587685A (en) * 1977-03-09 1981-04-08 Microbial Chem Res Found Macrolactone derivatives and their production
US4252898A (en) * 1979-05-23 1981-02-24 Eli Lilly And Company Antibiotics A6888C and A6888X
NL8004922A (nl) * 1979-09-19 1981-03-23 Toyo Jozo Kk Deformyltylosinederivaten.

Also Published As

Publication number Publication date
IL64240A (en) 1985-08-30
EP0052005A1 (en) 1982-05-19
EP0052005B1 (en) 1985-01-30
KR830007833A (ko) 1983-11-07
FI813527L (fi) 1982-05-11
DD202032A5 (de) 1983-08-24
BG36939A3 (en) 1985-02-15
GR75386B (el) 1984-07-13
KR850001666B1 (ko) 1985-11-13
IE812616L (en) 1982-05-10
GB2086902B (en) 1985-06-26
GB2086902A (en) 1982-05-19
ZA817718B (en) 1982-10-27
IL64240A0 (en) 1982-02-28
AU7731381A (en) 1982-05-20
DK494381A (da) 1982-05-11
PH17375A (en) 1984-08-06
PL233747A1 (el) 1982-11-22
JPS57108097A (en) 1982-07-05
CA1169374A (en) 1984-06-19
DE3168693D1 (en) 1985-03-14
PT73947B (en) 1983-11-30
IE51826B1 (en) 1987-04-01
HU190360B (en) 1986-08-28
US4304856A (en) 1981-12-08
AR227563A1 (es) 1982-11-15
PT73947A (en) 1981-12-01

Similar Documents

Publication Publication Date Title
US4321361A (en) Demycinosyltylosin and process for its production
US4559301A (en) Process for preparing macrocin derivatives
CS236663B2 (en) Manufacturing process of macro antibiotics 2%-dihydro-2%-deoxy-5-%-mycaminosyltylonolide
US4385116A (en) Demethylmacrocin and process for its production
CA1211731A (en) De(mycinosyloxy)tylosin derivatives
KR840001193B1 (ko) 마크로라이드 항생물질의 제조방법
US4419508A (en) 20-Dihydro-20-deoxy-23-demycinosyltylosin and process for its production
EP0042694A1 (en) Macrolide antibiotics
US4419447A (en) Fermentation process for producing demycinosyltylosin
US4486584A (en) Demethylmacrocin compounds and derivatives thereof
US4537957A (en) Process for the production of mycaminosyltylonolide
US4334019A (en) Process for producing de(mycinosyloxy)tylosin
US4528369A (en) 20-Dihydro-20-deoxy-23-de(mycinosyloxy)tylosin
US4656258A (en) Macrocin derivatives
CA1175423A (en) Method of preparing 23-deoxy-5-0- mycaminosyltylonolide
CA1175422A (en) Method of preparing 5-0-mycaminosyl-tylonolide